Novel artemisinin derivative FO8643 with anti-angiogenic activity inhibits growth and migration of cancer cells via VEGFR2 signaling

This publication has 78 references indexed in Scilit:

• Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
  The Lancet, 2012
• Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives
  Journal of Medicinal Chemistry, 2012
• Safety and pharmacokinetics of novel selective vascular endothelial growth factor receptor-2 inhibitor YN968D1 in patients with advanced malignancies
  BMC Cancer, 2010
• RACK1 promotes Bax oligomerization and dissociates the interaction of Bax and Bcl-XL
  Cellular Signalling, 2010
• Plethora of agents, plethora of targets, plethora of side effects in metastatic renal cell carcinoma
  Cancer Treatment Reviews, 2010
• Artesunate: The Best Drug in the Treatment of Severe and Complicated Malaria
  Pharmaceuticals, 2010
• AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
  Journal of Computational Chemistry, 2009
• VEGF receptor signalling ? in control of vascular function
  Nature Reviews Molecular Cell Biology, 2006
• Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2^−ΔΔC_T Method
  Methods, 2001
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971